RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
January 24, 2022 07:00 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
The PNS Trifecta: All Three SPRINT® PNS System Abstracts Submitted to ASRA 2021 Pain Medicine Meeting Receive President’s Choice Award
November 18, 2021 12:32 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Nov. 18, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics has been honored with three President’s Choice Abstract Awards at the 20th Annual ASRA Pain Medicine Meeting taking place November 18-20...
Inagene Diagnostics Inc. and The Newly Institute partner to optimize treatment for Canadians living with pain and/or mental health conditions
November 16, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically...
Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
November 09, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Focused on The Future of Innovation, Personalized Medicine and Genomics, the 21st Annual Healthcare Summit brought together global healthcare experts,...
Intrathecal Pumps Market Size ($513.24Mn by 2028) Growth Forecast at 5.3% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
October 07, 2021 07:08 ET
|
The Insight Partners
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Intrathecal Pumps Market: Key InsightsAccording to our new research study on “Intrathecal Pumps Market to 2028 – Global Analysis and Forecast – by Type,...
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Next Wave of Psychedelic Drug Development
September 30, 2021 08:30 ET
|
Tryp Therapeutics Inc.
NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “Investors Turning to Psychedelic...
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Redefining Standards, Refining Psychiatry
September 28, 2021 08:30 ET
|
Tryp Therapeutics Inc.
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
Medical Photobiostimulation System Market to Outstrip $314.88 Million by 2028 Growing Sturdy at 6.3% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
August 12, 2021 09:39 ET
|
The Insight Partners
Pune, INDIA., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Medical Photobiostimulation System Market: Key InsightsAccording to our new research study on “Medical Photobiostimulation System Market to 2028 –...
Leaf411: Increase in Opioid-related Overdoses Creates Urgency to Educate on Cannabis Treatments for Chronic Pain
August 10, 2021 11:00 ET
|
The 9th Block
DENVER, Aug. 10, 2021 (GLOBE NEWSWIRE) -- According to the U.S. Department of Health and Human Services, two-thirds of all drug overdoses in the country involve an opioid, and overdose deaths...
Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies
July 21, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic...